Home > Healthcare > Medical Devices > Therapeutic Devices > Structural Heart Devices Market

Structural Heart Devices Market Share

  • Report ID: GMI3231
  • Published Date: Feb 2024
  • Report Format: PDF
 Download Free Sample

Structural Heart Devices Market Share

The structural heart devices industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for structural heart devices manufacturers. Some of the leading industry players including Abbott Laboratories, Boston Scientific Corporation, Inc., Medtronic plc, Lepu Medical Technology (Beijing) Co., Ltd., and Edwards Lifesciences Corporation., Ltd, among others have a substantial presence in the market.
 

Structural Heart Devices Market Companies

Some of the eminent market participants operating in the structural heart devices industry include:

  • Abbott Laboratories
  • AtriCure, Inc.
  • Biomerics, LLC
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cryolife Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • NuMed Inc.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Structural heart devices industry size was USD 11.3 billion in 2023 and is expected to register 8.8% CAGR from 2024-2032 owing to the growing burden of cardiovascular diseases, favorable reimbursement scenarios and the rising preference for minimally invasive procedures worldwide.

The heart valve devices segment recorded over USD 4.7 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to the high incidence of heart diseases necessitating widespread adoption of devices.

North America structural heart devices industry reached USD 3.8 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a sophisticated healthcare infrastructure, coupled with high healthcare expenditure in the region.

AtriCure, Inc., Biomerics, LLC, Boston Scientific Corporation, Braile Biomedica, Cryolife Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Lepu Medical Technology (Beijing) Co., Ltd., and LivaNova PLC are some of the major structural heart devices companies worldwide.

Structural Heart Devices Market Scope

  • Structural Heart Devices Market Size
  • Structural Heart Devices Market Trends
  • Structural Heart Devices Market Analysis
  • Structural Heart Devices Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 12
    • Tables & Figures: 395
    • Countries covered: 22
    • Pages: 220
     Download Free Sample
    ×
    Get a free sample of Structural Heart Devices Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.